This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEI940J6_L.jpg
Japan in January expanded use of the vaccine to those as young as five years old. Last month, health authorities started to dispensing Pfizer and Moderna (NASDAQ:MRNA) Inc booster shots that target the Omicron variant of the virus.
The panel also recommended approval of a version of the Pfizer vaccine that protects against the BA.4 and BA.5 subvariants of Omicron. Moderna said earlier on Wednesday it was seeking Japanese approval of its own subvariant shot.
